首页> 外国专利> (Asu1.7) stabilization method null of aqueous solution injection medicine of karushitonin

(Asu1.7) stabilization method null of aqueous solution injection medicine of karushitonin

机译:(Asu1.7)稳定剂karushitonin的水溶液注射药物无效

摘要

PURPOSE:To provide the subject aqueous solution injection containing a specified pH buffer and stabilized in a wider pH range than in the conventional one. CONSTITUTION:In an aqueous solution injection containing an [Asu1.7] calcitonin, e.g. elcatonin or [Asu1.7] human calcitonin as the active component, one or two or more kinds of compounds selected from a group of tris(hydroxymethyl) aminomethane, an amine compound of the formula (R1 to R3 are each H or CH2-CH2-OH, at least one of them is CH2-CH2-OH) and water-soluble salts thereof are contained as the pH buffers so as to stabilize the pH within a range of 6.5 to 8. This aqueous solution injection contains 0.01 to 100mug/ml calcitonin and 0.05 to 100 mM pH buffers.
机译:目的:提供主题水溶液注射液,其中包含指定的pH缓冲液,并在比传统pH缓冲液宽的pH范围内稳定。组成:在含有[Asu <1.7>]降钙素的水溶液注射液中,例如降钙素或[Asu 1.7]人降钙素作为活性成分,选自三(羟甲基)氨基甲烷的一种或两种以上化合物,式(R1至R3的胺化合物)分别为H或CH2- CH2-OH,其中至少一种是CH2-CH2-OH),并包含其水溶性盐作为pH缓冲剂,以将pH稳定在6.5至8的范围内。该水溶液注射液中含有0.01至100 ug / ml降钙素和0.05至100 mM pH缓冲液。

著录项

  • 公开/公告号JP3262592B2

    专利类型

  • 公开/公告日2002-03-04

    原文格式PDF

  • 申请/专利权人 旭化成株式会社;

    申请/专利号JP19920189244

  • 发明设计人 佐藤 慎司;山田 仁;

    申请日1992-07-16

  • 分类号A61K38/23;A61K9/08;A61K47/18;

  • 国家 JP

  • 入库时间 2022-08-22 00:59:00

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号